NCT01125748.
Trial name or title | A study evaluating the persistency of response with or without Xolair after long‐term therapy (XPORT) |
Methods | Randomised, double‐blind, parallel‐group study |
Participants | Patients with allergic asthma 17 to 70 years of age |
Interventions | Omalizumab versus placebo |
Outcomes | Severe exacerbation |
Starting date | May 2010 |
Contact information | http://clinicaltrials.gov/ct2/show/NCT01125748 |
Notes |